SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-085903
Filing Date
2021-06-28
Accepted
2021-06-25 21:23:12
Documents
20
Period of Report
2021-06-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2120590d3_8k.htm   iXBRL 8-K 29899
2 EXHIBIT 1.1 tm2120590d3_ex1-1.htm EX-1.1 226803
3 EXHIBIT 5.1 tm2120590d3_ex5-1.htm EX-5.1 31754
4 EXHIBIT 99.1 tm2120590d3_ex99-1.htm EX-99.1 7886
5 EXHIBIT 99.2 tm2120590d3_ex99-2.htm EX-99.2 7092
9 GRAPHIC tm2120590d3_ex5-1ing002.jpg GRAPHIC 22301
10 GRAPHIC tm2120590d3_ex5-1ing001.jpg GRAPHIC 6279
11 GRAPHIC tm2120590d3_ex99-1img001.jpg GRAPHIC 4086
12 GRAPHIC tm2120590d3_ex99-2img003.jpg GRAPHIC 4086
  Complete submission text file 0001104659-21-085903.txt   598392

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tbph-20210624.xsd EX-101.SCH 3194
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbph-20210624_lab.xml EX-101.LAB 34593
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbph-20210624_pre.xml EX-101.PRE 22716
13 EXTRACTED XBRL INSTANCE DOCUMENT tm2120590d3_8k_htm.xml XML 3625
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 211049723
SIC: 2834 Pharmaceutical Preparations